Banook Group (FR) acquired Keosys Medical Imaging (FR), strengthening its presence in medical imaging technology for clinical trials.
| Acquirer | Banook Group |
|---|---|
| Target | Keosys Medical Imaging |
| Deal value | Undisclosed |
| Stake acquired | 100% |
| Close date | 2023-11-01 |
| Buy-side advisors | EGC (legal) |
| Sell-side advisors | S&W Partners Group (legal) |
Banook Group, a provider of technologies and services for clinical trial operators, acquired Keosys Medical Imaging to expand its technological offerings in medical imaging. The deal consolidates Banook's position as a leader in Europe for technology services in clinical trials.
Deal Mechanics
The acquisition was completed on November 1, 2023. While the financial terms of the transaction were not disclosed, legal advisors to both sides include EGC and S&W Partners Group respectively.
Strategic Rationale
Banook's strategy focuses on expanding its technological offerings for clinical trials through strategic acquisitions like Keosys Medical Imaging. Keosys is a renowned centralizer of medical images used in clinical trials, with expertise in oncology. This acquisition complements Banook’s existing services and enhances its ability to serve clients across Europe, North America, and Asia-Pacific.
Financial Context
Banook Group aims to become a global leader in technology service provision for clinical trials by offering a full suite of services. The group has nearly 120 employees spread across various regions globally, serving pharmaceutical labs, biotech firms, and contract research organizations.
Advisors
The deal was advised on the buy-side by EGC as legal counsel to Banook Group and S&W Partners Group for Keosys Medical Imaging on the sell-side. The financial advisors for both parties were not disclosed.
Outlook
With this acquisition, Banook Group anticipates accelerating its international development, particularly in the United States, while diversifying its service offerings and enhancing its technological capabilities. This strategic move positions Banook to meet growing demands from clients for comprehensive solutions in clinical trials.